Transaction · 0001829126-26-011084
TRXBTRex Bio, Inc.
Svlsf VI, LLC
SVLSF VI, LLC, 10%, reported an open-market or private purchase at TRex Bio, Inc. involving 3074.000000 shares for an estimated $43036.00. Reported holdings after the transaction were 7356.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Open-market buySEC transaction code P10%
- Trade date
- Oct 08, 2026
- Filing date
- Oct 13, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 4,282 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TRXB price since this filing
Daily closing prices, with the filing date and available return windowsTRXB · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001829126-26-011084 Common Stock
- Transaction date
- Oct 08, 2026 Filed Oct 13, 2026, 08:30 PM · 5d delay
- Shares
- 3,074 sh $14.00 per share
- Estimated value
- $43.0k Computed from shares × price
- Holdings after
- 7,356 sh Indirect · By SV Life Sciences Fund VI Strategic Partners, L.P.
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Buy Large Holdings Increase Repeat Buyer 10% Owner Buy
Filing-only score
+46 points
Compact filing score computed from stored Form 4 facts. Version v1.
Strong filing signal
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - ten_percent_owner_buy+4 points
is_ten_percent_owner = true
10% beneficial owner open-market purchase. - cluster_buy+14 points
cluster-buy signal matched
Multiple insiders bought within the configured window. - repeat_buyer+8 points
repeat-buyer signal matched
Same insider bought again within the configured window. - large_holdings_increase+8 points
large-holdings-increase signal matched
Reported acquired shares meet the configured percentage of post-transaction holdings.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector No10% YesOther No
Footnotes & amended
- F1
The shares are held directly by SV Life Sciences Fund VI, L.P. ("SV Fund VI"). SV Life Sciences Fund VI (GP), L.P. (the "GP LP") is the general partner of SV Fund VI, and SVLSF VI, LLC ("SVLSF") is th…
- F2
The shares are held directly by SV Life Sciences Fund VI Strategic Partners, L.P. ("SV Strategic Partners VI"). GP LP is the general partner of SV Strategic Partners VI, and SVLSF is the general partn…
- F3
The shares are held directly by SV Trex Coinvestment, L.P. ("SV Coinvestment"). GP LP is the general partner of SV Coinvestment, and SVLSF is the general partner of GP LP. Investment and voting decisi…
- F4
On October 13, 2026, 3.8649 shares of preferred stock automatically converted into one share of common stock upon the closing of the issuer's initial public offering, for no additional consideration.…
- F5
Represents shares purchased by SV Fund VI in the issuer's initial public offering.
- F6
Represents shares purchased by SV Strategic Partners VI in the issuer's initial public offering.
Related transactions
Same SEC filing0 other transactions
Recent company activity
TRXB0 recent txs